CSL Limited (CSLLY) stock price, news, quote and history

CSL (ASX:CSL) After New CEO Pick Still Looks Undervalued In The Leading Narrative

CSL appoints Deborah Waterhouse as CEO & Managing Director

A GSK-majority-owned HIV medicines company had £7.7B in sales in GSK's 2025 financial year. Its CEO will lead CSL.

CSL appoints ViiV Healthcare chief Deborah Waterhouse as CEO from February

Haemonetics shares jump as CSL sets 2027 rollout of plasma devices

Haemonetics stock surges 17% on CSL Plasma supply deal update

HRMY vs. CSLLY: Which Stock Is the Better Value Option?

CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases

A $355 million initial payment will go to Alentis for a drug aimed at rare kidney and liver diseases.

Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks

Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults

Haemonetics rises after supply deal with CSL

Is CSL An Unmissable Value Play? (OTCMKTS:CSLLY)

CSL Limited: Upside Potential Is Strong From These Levels, But I Remain Cautious (CMXHF)